ACT antimalarial (junior tablets)
Camosunate Junior is an artemisinin-based combination therapy (ACT) containing artesunate and amodiaquine, used for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum in children aged 7–13 years.
Active ingredients
Each tablet contains: Artesunate 100 mg + Amodiaquine 300 mg.
Pack size
1 × 6 tablets (blister pack).
How to use
Use only as directed by a healthcare professional. Follow the leaflet for dosing guidance.
Storage
Store in a cool, dry place away from heat and moisture.